Marksans Pharma Ltd - 524404 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE filing · raw filing ↗
20 Aug 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call UpdatesNSE filing · raw filing ↗
20 Aug 2026
⚑ Filing
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE filing · raw filing ↗
Ex-date 20 Aug 2026
⚑ Corp action
Dividend — ₹0.90 per shareNSE filing · record 20 Aug 2026
13 Aug 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call UpdatesNSE filing · raw filing ↗
Dividend — ₹0.80 per shareNSE filing · record 1 Aug 2025
Ex-date 17 Sep 2024
⚑ Corp action
Dividend — ₹0.60 per shareNSE filing · record 17 Sep 2024
Ex-date 7 Jun 2023
⚑ Corp action
Dividend — ₹0.50 per shareNSE filing · record 7 Jun 2023
Ex-date 19 Aug 2022
⚑ Corp action
Dividend — ₹0.25 per shareNSE filing
Ex-date 15 Sep 2021
⚑ Corp action
Dividend — ₹0.25 per shareNSE filing
Ex-date 22 Sep 2020
⚑ Corp action
Dividend — ₹0.10 per shareNSE filing
Ex-date 19 Sep 2019
⚑ Corp action
Dividend — ₹0.05 per shareNSE filing
Ex-date 19 Sep 2018
⚑ Corp action
Dividend — ₹0.05 per shareNSE filing
Ex-date 19 Sep 2017
⚑ Corp action
Dividend — ₹0.05 per shareNSE filing
Ex-date 22 Sep 2016
⚑ Corp action
Dividend — ₹0.12 per shareNSE filing
Ex-date 23 Sep 2015
⚑ Corp action
Dividend — ₹0.12 per shareNSE filing
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
